Aprecia Pharmaceuticals Company-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Aprecia Pharmaceuticals Company - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010847
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aprecia Pharmaceuticals Company (Aprecia) is a healthcare products provider that develops and markets various therapeutic products. The company’s zipdos technology platform is used in the production of sponge-like wafer forms of existing medicines. It also offers 3D printing technology platform that uses an aqueous fluid to stitch together multiple layers of powder using patent-protected process. Aprecia uses its 3DP technology platform to develop and manufacture pharmaceutical products. The company partners with various pharma companies to develop new technology solutions. Aprecia is headquartered in Langhorne, Pennsylvania, the US.

Aprecia Pharmaceuticals Company – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Aprecia Pharmaceuticals Company, Medical Devices Deals, 2011 to YTD 2017 9
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Aprecia Pharma Raises Funds in Financing Round 11
Aprecia Pharma Raises USD35 Million in Preferred Stock Financing 12
Aprecia Pharma Raises US$15 Million In Venture Financing 13
Aprecia Pharma Raises US$4 Million In Venture Financing 14
Aprecia Pharma Secures US$25.7 Million In Venture Financing 15
Partnerships 16
Aprecia Pharma and Cycle Pharma Enter into Agreement 16
Acquisition 17
Prasco Laboratories Acquires Additional stake in Aprecia Pharma 17
Aprecia Pharmaceuticals Company – Key Competitors 18
Aprecia Pharmaceuticals Company – Key Employees 19
Aprecia Pharmaceuticals Company – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Corporate Communications 21
Nov 01, 2017: Aprecia Pharmaceuticals Names University of Kentucky Provost as the Company’s Next CEO 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Key Facts 2
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aprecia Pharmaceuticals Company, Deals By Therapy Area, 2011 to YTD 2017 8
Aprecia Pharmaceuticals Company, Medical Devices Deals, 2011 to YTD 2017 9
Aprecia Pharmaceuticals Company, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Aprecia Pharma Raises Funds in Financing Round 11
Aprecia Pharma Raises USD35 Million in Preferred Stock Financing 12
Aprecia Pharma Raises US$15 Million In Venture Financing 13
Aprecia Pharma Raises US$4 Million In Venture Financing 14
Aprecia Pharma Secures US$25.7 Million In Venture Financing 15
Aprecia Pharma and Cycle Pharma Enter into Agreement 16
Prasco Laboratories Acquires Additional stake in Aprecia Pharma 17
Aprecia Pharmaceuticals Company, Key Competitors 18
Aprecia Pharmaceuticals Company, Key Employees 19
Aprecia Pharmaceuticals Company, Other Locations 20

★海外企業調査レポート[Aprecia Pharmaceuticals Company-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dakota Valley Electric Cooperative:企業の戦略的SWOT分析
    Dakota Valley Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Sequana SA (SEQ):企業の財務・戦略的SWOT分析
    Sequana SA (SEQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Imperial Dax Company, Inc:企業の戦略・SWOT・財務情報
    Imperial Dax Company, Inc - Strategy, SWOT and Corporate Finance Report Summary Imperial Dax Company, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • America Movil, SA DE C.V.:戦略・SWOT・企業財務分析
    America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report Summary America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Keio Corporation (9008):企業の財務・戦略的SWOT分析
    Keio Corporation (9008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Taikisha Ltd
    Taikisha Ltd - Strategy, SWOT and Corporate Finance Report Summary Taikisha Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Viridian Energy Supply Ltd:企業の戦略的SWOT分析
    Viridian Energy Supply Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Royal DSM NV (DSM):企業の財務・戦略的SWOT分析
    Royal DSM NV (DSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Xinjiang Goldwind Science & Technology Co Ltd (002202):電力:M&Aディール及び事業提携情報
    Summary Xinjiang GoldWind Science & Technology Co. Ltd. (Goldwind) is a wind energy company that manufactures wind turbine generator sets, develops wind farms and provides wind power services. The company researches, develops, manufactures and sells wind turbine generators and wind power components. …
  • Obsidian Energy Ltd (PWT)-石油・ガス分野:企業M&A・提携分析
    Summary Obsidian Energy Ltd (Obsidian) is formerly known as Penn West Petroleum Ltd it is a conventional oil and natural gas producer in Canada. It develops and explores oil and gas properties and related production infrastructure in the Western Canada Sedimentary Basin. Obsidian operates properties …
  • In-N-Out Burgers:企業の戦略・SWOT・財務情報
    In-N-Out Burgers - Strategy, SWOT and Corporate Finance Report Summary In-N-Out Burgers - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • United-Guardian Inc (UG):企業の財務・戦略的SWOT分析
    Summary United-Guardian Inc (United-Guardian) is a diversified company that manufactures and markets healthcare products. The company offers pharmaceuticals, cosmetic ingredients, health care products and proprietary industrial products, among others. It provides medical devices such as lubrajel flu …
  • Noevir Holdings Co Ltd (4928):企業の財務・戦略的SWOT分析
    Noevir Holdings Co Ltd (4928) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Metsa Group:企業の戦略・SWOT・財務情報
    Metsa Group - Strategy, SWOT and Corporate Finance Report Summary Metsa Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • El Al Israel Airlines Ltd.:戦略・SWOT・企業財務分析
    El Al Israel Airlines Ltd. - Strategy, SWOT and Corporate Finance Report Summary El Al Israel Airlines Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • AltaGas Ltd.:企業の戦略・SWOT・財務情報
    AltaGas Ltd. - Strategy, SWOT and Corporate Finance Report Summary AltaGas Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Galera Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Galera Therapeutics Inc (Galera Therapeutics) is a clinical stage biotechnology company that discovers and develops novel cancer treatments. The company also concentrates on the prevention of radiation-induced toxicity including mucositis and the treatment of cancer. Its GC4419 is a selectiv …
  • Levi Strauss & Co (LEVI):企業の財務・戦略的SWOT分析
    Levi Strauss & Co (LEVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • United Therapeutics Corp (UTHR):企業の財務・戦略的SWOT分析
    United Therapeutics Corp (UTHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Usha Martin Limited:企業の戦略・SWOT・財務情報
    Usha Martin Limited - Strategy, SWOT and Corporate Finance Report Summary Usha Martin Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆